Publications by authors named "Pouya Azarbar"

Cytomegalovirus (CMV) infection poses significant risks in allogeneic haematopoietic stem cell transplant (allo-HSCT) recipients. Despite advances in antiviral therapies, issues such as drug resistance, side effects, and inadequate immune reconstitution remain. This systematic review and meta-analysis aim to evaluate the efficacy and safety of adoptive cell therapy (ATC) in managing CMV infections in allo-HSCT recipients.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Pouya Azarbar"

  • - Pouya Azarbar's recent research focuses on the efficacy and safety of adoptive T-cell therapy for treating cytomegalovirus (CMV) infections following allogeneic haematopoietic stem cell transplantation (allo-HSCT).
  • - His systematic review and meta-analysis address the challenges in managing CMV infections, particularly in the context of antiviral drug resistance and inadequate immune responses in transplant recipients.
  • - The study highlights the potential benefits of adoptive T-cell therapy as a viable treatment option for CMV infections, aiming to improve patient outcomes in the transplant population.